BB Biotech Ventures logo

BB Biotech Ventures

Europe, Zurich, Switzerland, Zürich

Description

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.

Investor Profile

BB Biotech Ventures has made 48 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series C (23%)
  • Series A (19%)
  • Series B (19%)
  • Series Unknown (13%)
  • Series D (10%)
  • Post Ipo Equity (6%)
  • Series E (4%)
  • Private Equity (4%)
  • Series G (2%)

Country Focus

  • United States (56%)
  • Switzerland (23%)
  • Germany (6%)
  • The Netherlands (6%)
  • Ireland (4%)
  • Italy (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Health Diagnostics
  • Medical Device
  • Therapeutics
  • Biopharma
  • Women's
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BB Biotech Ventures frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 7
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 4
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 4
Consort Medical
Europe, Hertford, United Kingdom, Hemel Hempstead
Co-Investments: 4
IC
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 4
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 4

What are some of recent deals done by BB Biotech Ventures?

Molecular Templates

Austin, Texas, United States

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 28, 2024
Amount Raised: $9,500,000
Arvinas

New Haven, Connecticut, United States

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityNov 27, 2023
Amount Raised: $350,000,000
Molecular Templates

Austin, Texas, United States

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 13, 2023
Amount Raised: $40,000,000
Rivus Pharmaceuticals

Charlottesville, Virginia, United States

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

BiotechnologyHealth CareMedicalPharmaceutical
Series BSep 22, 2022
Amount Raised: $132,000,000
AM Pharma

Bunnik, Utrecht, The Netherlands

AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series UnknownMar 31, 2020
Amount Raised: $25,361,120
Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series EDec 16, 2019
Amount Raised: $8,135,803
Moderna

Cambridge, Massachusetts, United States

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Series GFeb 1, 2018
Amount Raised: $500,000,000
Binx Health

Boston, Massachusetts, United States

Binx Health is a healthcare technology company that makes testing more convenient and accessible to individuals.

Health CareHealth DiagnosticsMedical DeviceMobile
Series DJan 23, 2017
Amount Raised: $35,000,000
Abyrx

Irvington, New York, United States

Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures

BiotechnologyManufacturingMedicalMedical Device
Series UnknownDec 6, 2016
Amount Raised: $10,000,000
Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series CMay 27, 2016
Amount Raised: $18,000,000